Inactive Instrument

News Qiagen NV Deutsche Boerse AG

Equities

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

11:57am	Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	MT
21/06	Qiagen Seeks M&A	CI

Qiagen N : AGM 2024 Voting Results	04:55pm	PU
Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	03:27pm	MT
Qiagen Seeks M&A	21/06	CI
Transcript : Qiagen N.V. - Shareholder/Analyst Call	21/06
Qiagen N : Stifel – European Healthcare Summit Capital Markets Day Presentation	20/06	PU
Qiagen N : Stifel – European Healthcare Summit Infographic	20/06	PU
Sartorius on the downswing again - low since 2020 is approaching	19/06	DP
Invest Securities Raises Qiagen PT, Maintains Neutral Rating	19/06	MT
UBS Raises Qiagen Price Target to $46 From $44, Maintains Neutral Rating	18/06	MT
JPMorgan Raises Price Target on Qiagen to $54 From $52, Maintains Overweight Rating	18/06	MT
QIAGEN NV : Gets a Neutral rating from UBS	18/06	ZD
QIAGEN NV : Deutsche Bank reaffirms its Buy rating	18/06	ZD
QIAGEN NV : Berenberg remains its Buy rating	18/06	ZD
Frankfurt shares close: Dax recovers	17/06	DP
Transcript : Qiagen N.V. - Analyst/Investor Day	17/06
Dpa-AFX Overview: COMPANIES from 17.06.2024 - 15:15	17/06	DP
Qiagen Targets 7% Annual Sales Growth Through 2028	17/06	MT
Qiagen eyes sales growth of 7% per year until 2028	17/06	RE
QIAGEN announces 2028 strategy for solid profitable growth	17/06	AQ
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs	14/06	AQ

No results for this search

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 07:02 pm IST